The independent source for health policy research, polling, and news.
10,381-10,400 of 113,050 results
A report in the Wall Street Journal covers how medical expenses for therapy are impacting the U.S. during this time of inflation. Also: sugar substitutes' impact on blood glucose, a link between spirituality and heart health for Black Americans, tattoo ink worries, and more.
A survey from the Business Group on Health shows that the top driver of employers' care costs are from increasing diagnoses in late-stage cancer. Other health industry news includes data breaches, racism, and more.
Nearly half of the study participants who got psilocybin stopped drinking entirely, compared with 24% of the control group. The treatment is promising for people who don't respond to conventional approaches, said the director of the National Institute on Alcohol Abuse and Alcoholism.
The Health, Education, Labor and Pensions Committee hearing will happen mid-September and is designed to dig into the Biden administration's health officials' response to the monkeypox issue. Meanwhile, in San Francisco, there's quiet confidence the outbreak is slowing.
A study shows that new diagnoses rose 77% during the first year of covid for patients ages 8 to 21, with the average age being 14.4 years. Meanwhile, the World Health Organization reports that covid deaths are falling, down 15% globally in the last week.
The Israeli study looked at data from 109,000 people, though it confirmed the drug reduced the risk of hospitalization and death for high-risk seniors ages 65 and older. Meanwhile, first lady Jill Biden tested positive for a rebound case of covid after taking Paxlovid.
Media outlets cover details revealed by a House Oversight subcommittee. Even though hydroxychloroquine was already shown to be ineffective against covid, and possibly dangerous, Trump White House officials pressured the FDA to authorize it. TV personalities also had a role.
Stat reminds us it's less than a month since Amazon acquired One Medical, a "blockbuster" deal, but the retail giant will still shut down Amazon Care at the end of the year. The senior vice president of Amazon Health Services said it wasn't "the right long-term solution" for enterprise customers.
On Tuesday night, a federal judge blocked Biden administration guidance that requires doctors to provide abortions in emergency medical situations — the same guidance that was upheld by a different judge in Idaho.
The case centered around the Emergency Medical Treatment and Labor Act, known as EMTALA. Idaho's abortion law is still scheduled to take effect Thursday, minus the provision that the federal judge said the state cannot enforce for now.
The two Democratic senators have repeatedly stood in the way of President Joe Biden's domestic agenda. But their influence could wane in the next Congress if Democrats perform as strongly in the November elections as they have in recent primaries and special elections.
Today's early morning highlights from the major news organizations.
Editorial writers delve into these public health topics.
Opinion writers discuss covid and Dr. Fauci.
In Texas, where temperatures regularly climb into the triple digits, two-thirds of the state's prisons don't have air conditioning in living areas, The Texas Tribune reports. Inmates in Missouri and Kansas also must cope with scorching heat.
Read recent commentaries about drug-cost issues.
Read about the biggest pharmaceutical developments and pricing stories from the past week in KHN's Prescription Drug Watch roundup.
Axios says the study "cements the connection" between being healthy and financial stability, with financial hardship like medical debts following diagnoses of serious illnesses. Other medical debt news is reported alongside health industry matters.
The current program to aid access to baby formula for low-income parents is due to expire Sept. 30. In other news, experts are pushing the White House to work on lowering policing risks for racial minorities if the Food and Drug Administration bans menthol cigarettes.
The drug has been shown to fight monkeypox, but mainly in animal studies. Now, University of Oxford scientists are planning human trials. CIDRAP notes U.S. officials are involved in trials, too. Meanwhile, USA Today explains the Jynneos vaccine side effects.
© 2026 KFF